Today's Morning Movers and Top Ratings: BA, NVDA, TMO, MET and More

$Abercrombie & Fitch(ANF.US)$ stock rose 0.3% after the clothing retailer raised its forecast for fourth-quarter and annual net sales, after strong demand for its apparel brands during the key holiday shopping period.

$Moderna(MRNA.US)$ stock rose 1.5% after the drugmaker reported preliminary 2023 sales of $6.7 billion for its COVID vaccine, surpassing the lower end of its full-year forecast. "We are preparing for the launch of Moderna's second product, our RSV vaccine. 2024 is going to be an exciting year for the Company with multiple milestones across our nine late-stage programs. Through these product launches, we are focused on returning to sales growth in 2025,” said Stephane Bancel, Chief Executive Officer of Moderna.

$NVIDIA(NVDA.US)$ stock rose 0.6% after Reuters reported that the chipmaker is aiming to begin mass production of an artificial intelligence chip specifically designed for the Chinese market in the second quarter of 2024.

$Crocs(CROX.US)$ shares rose by 8% premarket after saying it now expects record 2023 revenues, above the analyst consensus expectation. The company sees 2023 revenues of approximately $3.95 billion, representing over 11% growth.

$Boeing(BA.US)$ shares fell 8.5% in U.S. premarket trading on Monday following the temporary grounding of some of its best-selling 737 MAX jets by the U.S. aviation regulator.

$Alaska Air(ALK.US)$ 's shares were down 4.3%, while $United Airlines(UAL.US)$ , the other U.S. carrier that operates the jet, was down 2.4%.